Multicenter double-blind randomized phase II: FOLFOX + ziv-aflibercept/placebo for patients (pts) with chemo-naive metastatic esophagogastric adenocarcinoma (MEGA).
暂无分享，去创建一个
C. Azzoli | J. Meyerhardt | C. Fuchs | P. Enzinger | D. Schrag | D. Rubinson | T. Abrams | M. Yurgelun | K. Ng | L. Goyal | G. Brooks | D. Savarese | J. Cleary | N. McCleary | Hui Zheng | J. Chan | M. Carey | Christopher Graham